BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 14523939)

  • 1. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions.
    Vives E
    J Mol Recognit; 2003; 16(5):265-71. PubMed ID: 14523939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
    Duchardt F; Fotin-Mleczek M; Schwarz H; Fischer R; Brock R
    Traffic; 2007 Jul; 8(7):848-66. PubMed ID: 17587406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms.
    Futaki S
    Biopolymers; 2006; 84(3):241-9. PubMed ID: 16333858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane permeability commonly shared among arginine-rich peptides.
    Futaki S; Goto S; Sugiura Y
    J Mol Recognit; 2003; 16(5):260-4. PubMed ID: 14523938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
    Ziegler A; Nervi P; Dürrenberger M; Seelig J
    Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
    Wadia JS; Dowdy SF
    Adv Drug Deliv Rev; 2005 Feb; 57(4):579-96. PubMed ID: 15722165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAT peptide internalization: seeking the mechanism of entry.
    Vivès E; Richard JP; Rispal C; Lebleu B
    Curr Protein Pept Sci; 2003 Apr; 4(2):125-32. PubMed ID: 12678851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAT transduction: the molecular mechanism and therapeutic prospects.
    Gump JM; Dowdy SF
    Trends Mol Med; 2007 Oct; 13(10):443-8. PubMed ID: 17913584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic TAT peptide transduction domain enters cells by macropinocytosis.
    Kaplan IM; Wadia JS; Dowdy SF
    J Control Release; 2005 Jan; 102(1):247-53. PubMed ID: 15653149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
    Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
    J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
    Gupta B; Levchenko TS; Torchilin VP
    Adv Drug Deliv Rev; 2005 Feb; 57(4):637-51. PubMed ID: 15722168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of static magnetic fields and tat peptides on cellular and nuclear uptake of magnetic nanoparticles.
    Smith CA; de la Fuente J; Pelaz B; Furlani EP; Mullin M; Berry CC
    Biomaterials; 2010 May; 31(15):4392-400. PubMed ID: 20189242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
    Morris MC; Depollier J; Mery J; Heitz F; Divita G
    Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain.
    Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE
    Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein/peptide transduction domains: potential to deliver large DNA molecules into cells.
    Snyder EL; Dowdy SF
    Curr Opin Mol Ther; 2001 Apr; 3(2):147-52. PubMed ID: 11338927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-penetrating peptides and proteins: new inhibitors of allergic airways disease.
    Kinyanjui MW; Fixman ED
    Can J Physiol Pharmacol; 2008; 86(1-2):1-7. PubMed ID: 18418441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating HIV1 TAT peptides float on model lipid bilayers.
    Ciobanasu C; Harms E; Tünnemann G; Cardoso MC; Kubitscheck U
    Biochemistry; 2009 Jun; 48(22):4728-37. PubMed ID: 19400584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine-rich cell-penetrating peptides.
    Schmidt N; Mishra A; Lai GH; Wong GC
    FEBS Lett; 2010 May; 584(9):1806-13. PubMed ID: 19925791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis.
    Nakase I; Tadokoro A; Kawabata N; Takeuchi T; Katoh H; Hiramoto K; Negishi M; Nomizu M; Sugiura Y; Futaki S
    Biochemistry; 2007 Jan; 46(2):492-501. PubMed ID: 17209559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.